Comparison of the therapeutic effect of injectable pantoprazole and famotidine in patients with epigastric pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230614058478N1

Enrollment

Registered

2024-03-06

Start date

2024-03-20

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epigastric pain. Pain localized to upper abdomen

Interventions

Intervention 1: Internention group: receiving 40 mg of famotidine injection diluted in 100ml of normal saline solution as a rapid infusion in 2-4 minutes. Intervention 2: Intervention group: receiving

Eligibility

Sex/Gender

All

Age

3 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with epigastric pain referred to the emergency department of Khatam Zahedan Hospital in 1401

Exclusion criteria

Exclusion criteria: - Unwillingness to participate in the study Pregnancy, patients with unstable vital signs, receiving antacids Receiving antacid/H2 receptor blockers/PPI within two hours before ED visit, known allergy to study agents Epigastric pain suspected of MI Age over 60 and under 18, cholecystitis, suspected dissection

Design outcomes

Primary

Measure	Time frame
Pain intensity after drug injection. Timepoint: 0-30-60 Minutes after receiving the medicine. Method of measurement: Assessing pain based on what is visible on the patient's face (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahjoube Keykha

Zahedan University of Medical Sciences

mahjoubehkeykha@zaums.ac.ir+98 54 3329 5765

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026